Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis
Public ClinicalTrials.gov record NCT01632540. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Investigation of the Real World Effectiveness of Beclomethasone Dipropionate (BDP) Nasal Aerosol in Perennial Allergic Rhinitis (PAR) Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will be a prospective observational study of "real world" BDP nasal aerosol users with PAR, with or without seasonal allergic rhinitis (SAR). Subjects will respond to monthly online surveys regarding rhinitis control, concomitant medical conditions, concomitant (non-AR) medications, current AR therapy, and adverse events.
Study identification
- NCT ID
- NCT01632540
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 824 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2012 (Type not available)
- Primary completion
- Dec 2013 (Actual)
- Completion
- Feb 2014 (Actual)
- Last update posted
- Apr 15, 2014
2012 – 2014
United States locations
- U.S. sites
- 46
- U.S. states
- 21
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 024 | Little Rock | Alaska | — | — |
| Teva Investigational Site 028 | Phoenix | Arizona | — | — |
| Teva Investigational Site 003 | Encinitas | California | — | — |
| Teva Investigational Site 042 | Fresno | California | — | — |
| Teva Investigational Site 006 | Los Angeles | California | — | — |
| Teva Investigational Site 017 | Orange | California | — | — |
| Teva Investigational Site 007 | Palmdale | California | — | — |
| Teva Investigational Site 021 | Paramount | California | — | — |
| Teva Investigational Site 040 | Redwood City | California | — | — |
| Teva Investigational Site 014 | Tallahassee | Florida | — | — |
| Teva Investigational Site 010 | Tamarac | Florida | — | — |
| Teva Investigational Site 038 | Albany | Georgia | — | — |
| Teva Investigational Site 031 | Lawrenceville | Georgia | — | — |
| Teva Investigational Site 035 | Savannah | Georgia | — | — |
| Teva Investigational Site 043 | Fort Mitchell | Kentucky | — | — |
| Teva Investigational Site 034 | Owensboro | Kentucky | — | — |
| Teva Investigational Site 033 | Mandeville | Louisiana | — | — |
| Teva Investigational Site 004 | Bethesda | Maryland | — | — |
| Teva Investigational Site 037 | Novi | Michigan | — | — |
| Teva Investigational Site 026 | Omaha | Nebraska | — | — |
| Teva Investigational Site 002 | Brick | New Jersey | — | — |
| Teva Investigational Site 019 | Corning | New York | — | — |
| Teva Investigational Site 018 | New York | New York | — | — |
| Teva Investigational Site 039 | Niagara Falls | New York | — | — |
| Teva Investigational Site 011 | High Point | North Carolina | — | — |
| Teva Investigational Site 027 | Winston-Salem | North Carolina | — | — |
| Teva Investigational Site 030 | Winston-Salem | North Carolina | — | — |
| Teva Investigational Site 013 | Toledo | Ohio | — | — |
| Teva Investigational Site 022 | Ashland | Oregon | — | — |
| Teva Investigational Site 016 | Eugene | Oregon | — | — |
| Teva Investigational Site 032 | Havertown | Pennsylvania | — | — |
| Teva Investigational Site 025 | Normal Square | Pennsylvania | — | — |
| Teva Investigational Site 012 | Pittsburgh | Pennsylvania | — | — |
| Teva Investigational Site 023 | Upland | Pennsylvania | — | — |
| Teva Investigational Site 015 | Dallas | Texas | — | — |
| Teva Investigational Site 029 | Dallas | Texas | — | — |
| Teva Investigational Site 009 | Fort Worth | Texas | — | — |
| Teva Investigational Site 020 | Houston | Texas | — | — |
| Teva Investigational Site 041 | San Antonio | Texas | — | — |
| Teva Investigational Site 044 | San Antonio | Texas | — | — |
| Teva Investigational Site 046 | San Antonio | Texas | — | — |
| Teva Investigational Site 001 | Waco | Texas | — | — |
| Teva Investigational Site 005 | Murray | Utah | — | — |
| Teva Investigational Site 045 | Newport News | Virginia | — | — |
| Teva Investigational Site 008 | Puyallup | Washington | — | — |
| Teva Investigational Site 036 | Greenfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01632540, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2014 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01632540 live on ClinicalTrials.gov.